22nd Century Group reports Q3 revenue up 66% to $4.8M

22nd Century Group (XXII) reported Q3 revenue of $4.8M, up 66% from Q2. Gross profit is expected at $0.4M, with operating and net losses narrowing. Cash and equivalents stood at $3.9M. Full earnings to be released by November 13, 2026. Figures are preliminary and unaudited.

Original reporting
Published Oct 22, 2026, 2:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 2:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$XXII
Bullish
medium confidence
Mentioned
$XXII
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$XXIIBullishMed
01

Why it matters

The preliminary numbers could trigger short‑term buying interest, but the company remains loss‑making.

02

Market read

Micro‑cap earnings surprise with modest absolute scale; likely limited but immediate price move.

03

What to watch

Potential regulatory risk in low‑nicotine products could offset earnings upside.

Relevance 5/10Novelty 6/10Timing: pre‑market today

Background

22nd Century Group, a low‑nicotine tobacco manufacturer, released unaudited Q3 figures showing a sharp revenue increase.

Company-level read

Ticker impact

$XXIIBullishMedium confidence
Context

Preliminary Q3 revenue rose 66% to $4.8M, beating prior quarter.

Expected impact

likely upward pressure as market absorbs the revenue beat

Evidence & confidence

Small‑cap stocks react strongly to earnings surprises; the 66% revenue increase is material for XXII.

Market effects

Limited to low‑cost tobacco niche; modest impact on broader consumer sector.

Minor effect on US small‑cap market.

Low

Counterpoint

Revenue growth may be temporary; cost structure still yields operating loss.

Key entities

  • 22nd Century Group

    Low‑nicotine tobacco products manufacturer

Related articles

$XXIIMed

22nd Century Group Reports Second Quarter 2026 Financial Results

22nd Century Group, Inc. (XXII) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 22nd Century Group Reports Second Quarter 2026 Financial Results Advances VLN ® Commercialization Through Expanded Retail Support and Brand-Building Initiatives MOCKSVILLE, N.C., August 13, 2026 —22nd Century Group, Inc. (Nasdaq: XXII), the leader in low-nicotine tob

$ONONMed

ON Holding earnings analysis: questions answered and next catalysts

ON Holding AG (ONON) reported Q3 2026 earnings with EPS of $0.54 (beating estimates by 42.11%) and revenue of $931.40M (in line with expectations). Despite the earnings beat, shares fell 8.07% intraday. The company has shown sequential revenue growth and consistent EPS beats, but revenue estimates have slightly declined. Next catalysts include Q4 earnings, product launches, and wholesale trends.

$RKLBMedAI 8/10

Rocket Lab earnings analysis: questions answered and next catalysts

Rocket Lab Corp (RKLB) reported Q3 FY2026 revenue of $268.0M, beating estimates, but missed earnings with EPS of -$0.12. Backlog grew to $3.6B, and Neutron launches were priced higher. The stock initially dropped but reversed, trading at $60.69. Unresolved issues include Neutron delays and cost overruns. Next catalysts include Iridium approval, Neutron progress, and Q4 results.

$OXYMedAI 8/10

Occidental Petroleum earnings analysis: questions answered and next catalysts

Occidental Petroleum (OXY) reported Q3 2026 earnings with adjusted EPS of $1.91, beating estimates by 42.5%, while revenue was $6.57B, slightly below expectations. Shares are up 35.91% YTD but down 7.25% over the past week. The company reduced debt by $1.8B in the quarter and generated $2.8B in free cash flow. Analysts remain cautious about oil price sensitivity and Gulf of Mexico production issues. Next catalysts include the Q3 earnings call on Nov 10 and Q4 earnings on Feb 24, 2027.

$IHRTHighAI 8/10

Why is iHeartMedia stock collapsing today?

iHeartMedia's stock fell 66.1% to $0.60 after Q3 2026 results missed expectations, with revenue at $1.03B (vs. $1.07B estimate) and adjusted EBITDA at $170M (vs. $201M estimate). The company cut full-year adjusted EBITDA guidance to $550M-$600M from ~$800M, citing weak broadcast radio performance and macroeconomic concerns.